These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 21833889)

  • 1. [Discontinuation of biologicals in rheumatoid arthritis after acquiring remission? Yes].
    Rubbert-Roth A
    Dtsch Med Wochenschr; 2011 Aug; 136(33):1674. PubMed ID: 21833889
    [No Abstract]   [Full Text] [Related]  

  • 2. [Discontinuation of biologicals in rheumatoid arthritis after acquiring remission? No].
    Grünke M
    Dtsch Med Wochenschr; 2011 Aug; 136(33):1675. PubMed ID: 21833890
    [No Abstract]   [Full Text] [Related]  

  • 3. [Rheumatoid arthritis: milestones in classification and treatment].
    Fiehn C
    Dtsch Med Wochenschr; 2011 Feb; 136(5):203-5. PubMed ID: 21271482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The BeSt story: on strategy trials in rheumatoid arthritis.
    Klarenbeek NB; Allaart CF; Kerstens PJ; Huizinga TW; Dijkmans BA
    Curr Opin Rheumatol; 2009 May; 21(3):291-8. PubMed ID: 19318946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Against parenteral gold therapy in rheumatoid arthritis].
    Kellner H
    Dtsch Med Wochenschr; 2011 Aug; 136(33):1677. PubMed ID: 21833892
    [No Abstract]   [Full Text] [Related]  

  • 6. [Indications for and use of biologics in early rheumatoid arthritis based on the evidence].
    Takeuchi T
    Nihon Rinsho; 2009 May; 67(5):1043-9. PubMed ID: 19432131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are there special considerations relevant to trials of biologic agents?
    Strand V
    J Rheumatol Suppl; 1994 Sep; 41():41-5; discussion 45-9. PubMed ID: 7799384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unresolved issues in identifying and overcoming inadequate response in rheumatoid arthritis: weighing the evidence.
    Cohen SB; Cohen MD; Cush JJ; Fleischmann RM; Mease PJ; Schiff MH; Simon LS; Weaver AL
    J Rheumatol Suppl; 2008 Feb; 81():4-30; quiz 31-4. PubMed ID: 19193621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Early use of biological agents after first DMARD in rheumatoid arthritis - no].
    Keyßer G
    Dtsch Med Wochenschr; 2013 Dec; 138(50):2620. PubMed ID: 24301498
    [No Abstract]   [Full Text] [Related]  

  • 10. [Early use of biological agents after first DMARD in rheumatoid arthritis - no].
    Thomann U
    Dtsch Med Wochenschr; 2013 Dec; 138(50):2620. PubMed ID: 24301497
    [No Abstract]   [Full Text] [Related]  

  • 11. [Early use of biological agents after first DMARD in rheumatoid arthritis--no].
    Keyßer G
    Dtsch Med Wochenschr; 2013 Sep; 138(37):1851. PubMed ID: 24006169
    [No Abstract]   [Full Text] [Related]  

  • 12. Rheumatoid arthritis.
    Lorenzo M
    Foot Ankle Clin; 2007 Sep; 12(3):525-37, vii. PubMed ID: 17765843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The safety of biological medicines for rheumatoid arthritis.
    Papadopoulos I; Demetzos C; Markantoni-Kyroudi S; Souliotis K
    Adv Exp Med Biol; 2015; 822():209-10. PubMed ID: 25416994
    [No Abstract]   [Full Text] [Related]  

  • 14. Innovative treatment strategies for patients with rheumatoid arthritis.
    van der Kooij SM; Allaart CF; Dijkmans BA; Breedveld FC
    Curr Opin Rheumatol; 2008 May; 20(3):287-94. PubMed ID: 18388520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can disease-modifying anti-rheumatic drugs be discontinued in long-standing rheumatoid arthritis? A 15-year follow-up.
    Tiippana-Kinnunen T; Paimela L; Kautiainen H; Laasonen L; Leirisalo-Repo M
    Scand J Rheumatol; 2010; 39(1):12-8. PubMed ID: 20132065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do all drugs and treatments for rheumatoid arthritis have the same efficacy?
    Weisman MH
    Nat Clin Pract Rheumatol; 2008 Jun; 4(6):298-9. PubMed ID: 18431369
    [No Abstract]   [Full Text] [Related]  

  • 17. Remission in rheumatoid arthritis: wishful thinking or clinical reality?
    Sesin CA; Bingham CO
    Semin Arthritis Rheum; 2005 Dec; 35(3):185-96. PubMed ID: 16325659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of biologicals in early rheumatoid arthritis.
    Haque UJ; Bathon JM
    Best Pract Res Clin Rheumatol; 2005 Feb; 19(1):179-89. PubMed ID: 15588978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment and management of rheumatoid arthritis.
    Haraoui B
    J Rheumatol Suppl; 2009 Jun; 82():2-10. PubMed ID: 19509324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative overview of safety of the biologics in rheumatoid arthritis.
    Khraishi M
    J Rheumatol Suppl; 2009 Jun; 82():25-32. PubMed ID: 19509327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.